New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

Alzheimer's experts say success would usher in a convenient new treatment to slow progression of the mind-robbing disease defined by toxic amyloid plaques in the brain that affects 50 million people ...

New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the potential for additional long-term clinical benefits with continued ...

A large new study from Saint Louis University has found that older adults who have both depression and insomnia are at much ...

Seth and Lauren Rogen’s Hilarity for Charity raised $1.3M at its annual Friendsgiving, blending comedy, music and support for ...

In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a disease for which we had no name, no cause and no hope. As an infectious ...

Individuals with type 1 diabetes who were not obese showed a fourfold increased risk for dementia (hazard ratio [HR], 4.0; 95 ...

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss ...

The Augusta County community raised $80,000 to help support the care, support and research programs of the Alzheimer’s ...

Racing to End Alzheimer's with Stephen Cameron Racing team will be back on track in 2026, returning to the IMSA Michelin ...